Healthcare Business
Latest News
Current Treatment Algorithm for Management of Immune Thrombocytopenia
An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, blee...
How Hospital Pharmacies Are Tackling Rising Drug Costs
A new report from Bluesight reveals how automation and analytics are helping hospital pharmacy teams cut spending, manage shortages, and streamline pr...
Use of GLP-1 RAs Associated With Increased Risk of NAION in Patients With Diabetes
Results confirm previous findings that nonarteritic anterior ischemic optic neuropathy (NAION) was more likely in those who used semaglutide, a glucag...
FDA Approves Dordaviprone as First and Only Treatment for Aggressive Form of Glioma
Dordaviprone (Modeyso) is now approved to treat recurrent H3 K27M-mutant diffuse midline glioma, an ultra-rare, aggressive brain tumor primarily affec...
Immune Checkpoint Inhibitors More Effective vs Bevacizumab in Nonsquamous NSCLC
Bevacizumab combined with chemotherapy was not as effective in advanced driver gene-negative nonsquamous non–small cell lung cancer (NSCLC) compared w...
RFK Jr Axes $500 Million in Funding for mRNA Vaccine Development
Robert F. Kennedy Jr halted 22 mRNA vaccine initiatives, drawing criticism from health experts over pandemic preparedness concerns.
Current Treatment Algorithm for Management of Immune Thrombocytopenia
How Hospital Pharmacies Are Tackling Rising Drug Costs
Use of GLP-1 RAs Associated With Increased Risk of NAION in Patients With Diabetes
FDA Approves Dordaviprone as First and Only Treatment for Aggressive Form of Glioma
Immune Checkpoint Inhibitors More Effective vs Bevacizumab in Nonsquamous NSCLC
RFK Jr Axes $500 Million in Funding for mRNA Vaccine Development
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago